AbCellera Biologics Inc. (ABCL)
Nasdaq: ABCL · Pharmaceutical Preparations · Vancouver, BC · filing with the SEC since 2017
Who owns AbCellera Biologics Inc.
As filed with the SECHolders of 5% or more
1
Baker Bros. Advisors LP holds 10.8% of Common Shares, no par value per share, as its SCHEDULE 13G/A filed May 7, 2026 says.
Directors and officers
9
report now, of 13 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Baker Bros. Advisors LP
SCHEDULE 13G/A · filed May 7, 2026 · Common Shares, no par value per share
Baillie Gifford & Co
SCHEDULE 13G/A · filed Oct 9, 2024 · Ordinary Shares · reported falling below 5%
What ABCL reports owning in othersstakes of 5% or more, and other ties
8 subsidiaries in 3 countries, from the list filed with the 10-K filed Feb 24, 2026.
Insider tradesForm 4
0sales
7purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$2.0Mbought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 21 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Montalbano John S. | director | 0 | $0 | 0 | 3 | $400,000 |
| Thermopylae Holdings Ltd. | 10% owner | 0 | $0 | 0 | 3 | $1.4M |
| Booth Andrew | Chief Financial Officer | 0 | $0 | 0 | 2 | $500,000 |
| Hayden Michael R | director | 0 | $0 | 0 | 2 | $1.1M |